Percutaneous Treatment of Multivalvular Disease Including Refractory Tricuspid Regurgitation in a Frail Elderly Patient
Frailty and associated comorbidities remain pivotal challenges and require diligent postprocedural follow-up, but they are not absolute contraindications for percutaneous treatment.
Authors
- Francisco Monteiro de Almeida Magalhães (ORCID: https://orcid.org/0000-0003-3776-1914)
- Lisandro Ribeiro (ORCID: https://orcid.org/0000-0003-2938-5146)
- Henrique Trombini Pinesi (ORCID: https://orcid.org/0000-0002-3973-7523)
- Vinícius Esteves (ORCID: https://orcid.org/0000-0003-1152-8946)
- Fernanda Esteves
- R. Lee Franco (ORCID: https://orcid.org/0000-0001-7235-8413)
Institutions
- University Hospitals of Cleveland (US)
- D’Or Institute for Research and Education (BR)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.jaccas.2025.104666
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00